Two Sigma Securities’s Curanex Pharmaceuticals CURX Stock Holding History

Two Sigma Securities’s Portfolio CURX Stock Details CURX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29K	Buy	+56,651	New	+$21.3K	﹤0.01%	1324
2025 Q4	–	Sell	-32,435	Closed	-$23.4K	–	2179
2025 Q3	$23.4K	Buy	+32,435	New	+$147K	﹤0.01%	1111

Other funds holding CURX

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Securities's CURX Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Curanex Pharmaceuticals (CURX) in Q1 2026: 56,651 shares worth $29K. The stake represents ﹤0.01% of the portfolio and ranks #1324 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CURX as recently as Q3 2025.

Two Sigma Securities first reported a position in CURX in Q3 2025 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold CURX as of Q1 2026.

Two Sigma Securities held 56,651 shares of Curanex Pharmaceuticals worth $29K as of Q1 2026.
Curanex Pharmaceuticals was a new Two Sigma Securities position in Q1 2026.
Curanex Pharmaceuticals made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1324 holding.
Two Sigma Securities first reported a position in Curanex Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
8 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.